Which methods can effectively treat bile duct cancer

Which methods can effectively treat bile duct cancer? Biliary duct cancer is a multiple malignant tumor disease. This disease is not easy to control. Once it occurs, it will cause great harm to the patient's body, and the disease progresses very quickly. It is not easy to effectively treat it. So which methods can effectively treat bile duct cancer?

1. Treatment of bile duct cancer with traditional Chinese medicine

A large number of clinical practices have proved that high-dose radiotherapy and chemotherapy for patients in the middle and late stages, or chemotherapy again for patients who have developed drug resistance, can only make the weak life more critical and accelerate the death of the patient. It is often seen in the clinic that the cause of death of patients is not caused by the cancer itself, but by unscientific and inappropriate lethal treatment. For example, after multiple interventions for liver cancer, ascites, jaundice and other liver failure occurred, leading to death; lung cancer pleural effusion chemotherapy led to respiratory failure and death; nausea and vomiting after chemotherapy for gastric cancer and intestinal cancer made the patient more exhausted and died; white blood cell count decreased, and the patient died of infection, etc.

Traditional Chinese medicine can make up for the deficiencies of surgical treatment, radiotherapy, and chemotherapy. It can not only consolidate the effects of radiotherapy and chemotherapy, but also eliminate the toxic side effects of radiotherapy and chemotherapy.

Biliary duct cancer tips:

In the early stage of jaundice of bile duct cancer, TCM is used to reduce adverse reactions and stop vomiting, soothe the liver and promote bile secretion, remove jaundice and dampness, so as to facilitate urination, remove jaundice and nourish, and control tumors. In the late stage, after bile duct drainage by Western medicine, TCM is used in a timely manner to strengthen the body, soothe the liver and promote bile secretion. Strengthen the body, eliminate evil, and restore immunity and organ functions.

2. Surgical treatment of bile duct cancer

(1) Choice of surgical method for resectable hilar cholangiocarcinoma:

① Resection of the hilar bile duct, common bile duct and cholecystectomy, and choledochojejunostomy. Applicable to common hepatic duct cancer that has not invaded the liver parenchyma.

② Resection of the quadratic lobe of the liver or part of the right anterior lobe, resection of the hilar bile duct and extrahepatic bile duct, and choledochojejunostomy. Applicable to common hepatic duct cancer or confluent bile duct cancer.

③ Resection of the quadratic lobe or left hemihepatectomy and resection of the hilar bile duct and extrahepatic bile duct, and cholechojejunostomy. Applicable to left hepatic duct and common hepatic duct cancer.

④ Resection of the quadratic lobe or right hemihepatectomy and resection of the hilar bile duct and extrahepatic bile duct, and cholechojejunostomy. Applicable to right hepatic duct and common hepatic duct cancer.

⑤ Super hemihepatectomy or trihepatectomy and resection of the hilar bile duct, extrahepatic bile duct, and part of the caudate lobe, and choledochojejunostomy. Applicable to left or right hepatic duct cancer invading the secondary or higher hepatic duct and the caudate lobe hepatic duct.

⑥ Palliative resection: resection of the quadrate lobe of the liver and the hilar bile duct, extrahepatic bile duct, and choledochojejunostomy, with some residual cancerous tissue such as the caudate lobe hepatic duct or the anterior wall of the portal vein.

⑦ If the main trunk, confluence or anterior wall of the left and right trunks of the portal vein are invaded, the affected part of the venous wall is removed and the blood vessels are repaired and reconstructed, supplemented with intracavitary radiotherapy after surgery.

(2) Palliative surgery for hilar cholangiocarcinoma: Bilioenteric drainage is the preferred palliative surgical method. The principle is that the bilioenteric anastomosis should be as far away from the lesion as possible. The site of bilioenteric anastomosis is selected according to the dilated bile duct shown by PTC. In some cases, due to the invasion of the hilar lesion or the presence of liver atrophy-hypertrophy complex, the value of anastomosis and drainage of the atrophic lobe bile duct is not great.

The hypertrophic lobe bile duct is difficult to expose, so many cases that cannot be resected can only be drained by catheter placement. The commonly used method is to dilate the cancerous stricture and place a T-tube, U-tube or internal support catheter that is as thick and hard as possible. The T-tube can be led out through the common bile duct or through the liver. In order to prevent slippage, the drainage tube should be sutured and fixed to the bile duct wall and surrounding tissues, and an upper jejunostomy should be made for postoperative bile infusion and tube feeding when necessary. The commonly used method of non-surgical catheter drainage is PTCD, and the internal support tube can also be placed after the PTCD sinus is expanded. Pass through the stricture.

(3) Resection of middle and lower bile duct cancer: Middle and lower bile duct cancer is less common than hilar and papillary cancer. Currently, most scholars recommend resection of the head of the pancreas and duodenum for its surgical treatment. If the middle and lower bile duct cancer cannot be removed, the above palliative methods can be used.